Tricellulin expression in normal and neoplastic human pancreas

Histopathology

Volumn 60, Issue 6 B, 2012, Pages

  Korompay, Anna ^a   Borka, Katalin ^a   Lotz, Gábor ^a   Somorácz, Áron ^a   Törzsök, Péter ^a   Erdélyi Belle, Boglárka ^a   Kenessey, István ^a   Baranyai, Zsolt ^b   Zsoldos, Fanni ^a   Kupcsulik, Péter ^a   Bodoky, György ^c   Schaff, Zsuzsa ^a   Kiss, András ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UZSOKI HOSPITAL   (Hungary)

^c Szent Laszlo Hospital   (Hungary)

Author keywords

Pancreas; Pancreatic cancer; Tight junction; Tricellulin

Indexed keywords

MEMBRANE PROTEIN; TRICELLULIN; UNCLASSIFIED DRUG;

ACINAR CELL CARCINOMA; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS ISLET CELL CARCINOMA; PANCREAS ISLET CELL TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MARVEL DOMAIN CONTAINING 2 PROTEIN; MEMBRANE PROTEINS; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84860349932     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2012.04189.x     Document Type: Article

References (57)

1. Furuse M. Knockout animals and natural mutations as experimental and diagnostic tool for studying tight junction functions invivo. Biochim. Biophys. Acta 2009; 1788; 813-819.
2. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2001; 2; 285-293.
3. Kondoh M, Yagi K. Tight junction modulators: promising candidates for drug delivery. Curr. Med. Chem. 2007; 14; 2482-2488.
4. Tsukita S, Yamazaki Y, Katsuno T, Tamura A. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 2008; 27; 6930-6938.
5. Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J. Cell Biol. 2005; 171; 939-945.
6. Ikenouchi J, Sasaki H, Tsukita S, Furuse M. Loss of occludin affects tricellular localization of tricellulin. Mol. Biol. Cell 2008; 19; 4687-4693.
7. Staehelin LA. Further observations on the fine structure of freeze-cleaved tight junctions. J. Cell Sci. 1973; 13; 763-786.
8. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 1993; 123; 1777-1788.
9. Tsukita S, Furuse M. Overcoming barriers in the study of tight junction functions: from occludin to claudin. Genes Cells 1998; 3; 569-573.
10. Lal-Nag M, Morin PJ. The claudins. Genome Biol. 2009; 10; 235.
11. Riazuddin S, Ahmed ZM, Fanning AS et al. Tricellulin is a tight-junction protein necessary for hearing. Am. J. Hum. Genet. 2006; 79; 1040-1051.
12. Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim. Biophys. Acta 2008; 1778; 588-600.
13. Westphal JK, Dorfel MJ, Krug SM et al. Tricellulin forms homomeric and heteromeric tight junctional complexes. Cell. Mol. Life Sci. 2010; 67; 2057-2068.
14. Gonzalez-Mariscal L, Lechuga S, Garay E. Role of tight junctions in cell proliferation and cancer. Prog. Histochem. Cytochem. 2007; 42; 1-57.
15. Singh AB, Sharma A, Dhawan P. Claudin family of proteins and cancer: an overview. J. Oncol. 2010; DOI: 10.1155/2010/541957.
16. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem. Cell Biol. 2008; 130; 55-70.
17. Kominsky SL, Argani P, Korz D et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma insitu and invasive ductal carcinoma of the breast. Oncogene 2003; 22; 2021-2033.
18. Borka K, Kaliszky P, Szabo E et al. Claudin expression in pancreatic endocrine tumors as compared with ductal adenocarcinomas. Virchows Arch. 2007; 450; 549-557.
19. Comper F, Antonello D, Beghelli S et al. Expression pattern of claudins 5 and 7 distinguishes solid-pseudopapillary from pancreatoblastoma, acinar cell and endocrine tumors of the pancreas. Am. J. Surg. Pathol. 2009; 33; 768-774.
20. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006; 6; 186; DOI:10.1186/1471-2407-6-186.
21. Karanjawala ZE, Illei PB, Ashfaq R et al. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am. J. Surg. Pathol. 2008; 32; 188-196.
22. Perou CM. Molecular stratification of triple-negative breast cancers. Oncologist 2011; 16(Suppl. 1); 61-70.
23. Sun C, Yi T, Song X et al. Efficient inhibition of ovarian cancer by short hairpin RNA targeting claudin-3. Oncol. Rep. 2011; 26; 193-200.
24. Yamaguchi H, Kojima T, Ito T et al. Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells. Am. J. Pathol. 2010; 177; 698-712.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72; 248-254.
26. Hsu CC, Tsai WC, Chen CP, Lu YM, Wang JS. Effects of negative pressures on epithelial tight junctions and migration in wound healing. Am. J. Physiol. Cell Physiol. 2010; 299; C528-C534.
27. Brennan K, Offiah G, McSherry EA, Hopkins AM. Tight junctions: a barrier to the initiation and progression of breast cancer? J. Biomed. Biotechnol. 2010; DOI:10.1155/2010/460607.
28. Morin PJ. Claudin proteins in ovarian cancer. Dis. Markers 2007; 23; 453-457.
29. Sobel G, Paska C, Szabo I, Kiss A, Kadar A, Schaff Z. Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum. Pathol. 2005; 36; 162-169.
30. Szabo I, Kiss A, Schaff Z, Sobel G. Claudins as diagnostic and prognostic markers in gynecological cancer. Histol. Histopathol. 2009; 24; 1607-1615.
31. Escudero-Esparza A, Jiang WG, Martin TA. The claudin family and its role in cancer and metastasis. Front. Biosci. 2011; 16; 1069-1083.
32. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci. 2003; 94; 575-581.
33. Martin TA, Mason MD, Jiang WG. Tight junctions in cancer metastasis. Front. Biosci. 2011; 16; 898-936.
34. Martin TA, Jiang WG. Loss of tight junction barrier function and its role in cancer metastasis. Biochim. Biophys. Acta 2009; 1788; 872-891.
35. Tokes AM, Kulka J, Paku S et al. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res. 2005; 7; R296-R305.
36. Al Moustafa AE, Alaoui-Jamali MA, Batist G et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002; 21; 2634-2640.
37. Katoh M. CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int. J. Mol. Med. 2003; 11; 683-689.
38. de Oliveira SS, de Oliveira IM, De Souza W, Morgado-Diaz JA. Claudin upregulation in human colorectal cancer. FEBS Lett. 2005; 579; 6179-6185.
39. Gyorffy H, Holczbauer A, Nagy P et al. Claudin expression in Barrett's esophagus and adenocarcinoma. Virchows Arch. 2005; 447; 961-968.
40. Lodi C, Szabo E, Holczbauer A et al. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas. Mod. Pathol. 2006; 19; 460-469.
41. Nishino R, Honda M, Yamashita T et al. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma. J. Hepatol. 2008; 49; 207-216.
42. Cheung ST, Leung KL, Ip YC et al. Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin. Cancer Res. 2005; 11; 551-556.
43. Iovanna J, Neira JL. Pancreatic cancer: molecular, biochemical, chemopreventive, and therapeutic aspects. ScientificWorldJournal 2010; 10; 1967-1970.
44. Kleeff J, Michalski C, Friess H, Buchler MW. Pancreatic cancer: from bench to 5-year survival. Pancreas 2006; 33; 111-118.
45. Nemeth Z, Szasz AM, Tatrai P et al. Claudin-1, -2, -3, -4, -7, -8, and -10 protein expression in biliary tract cancers. J. Histochem. Cytochem. 2009; 57; 113-121.
46. Krug SM, Amasheh S, Richter JF et al. Tricellulin forms a barrier to macromolecules in tricellular tight junctions without affecting ion permeability. Mol. Biol. Cell 2009; 20; 3713-3724.
47. Masuda R, Semba S, Mizuuchi E, Yanagihara K, Yokozaki H. Negative regulation of the tight junction protein tricellulin by snail-induced epithelial-mesenchymal transition in gastric carcinoma cells. Pathobiology 2010; 77; 106-113.
48. Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J. Pathol. 2006; 208; 633-642.
49. Offner S, Hekele A, Teichmann U et al. Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy. Cancer Immunol. Immunother. 2005; 54; 431-445.
50. Szasz AM, Nemeth Z, Gyorffy B et al. Identification of a claudin-4/E-cadherin score (CURIO) to predict prognosis in breast cancer. Cancer Sci. 2011; 102; 2248-2254.
51. Yoshida H, Sumi T, Zhi X, Yasui T, Honda K, Ishiko O. Claudin-4: a potential therapeutic target in chemotherapy-resistant ovarian cancer. Anticancer Res. 2011; 31; 1271-1277.
52. Saeki R, Kondoh M, Kakutani H et al. A novel tumor-targeted therapy using a claudin-4-targeting molecule. Mol. Pharmacol. 2009; 76; 918-926.
53. Schlüter H, Moll I, Wolburg H et al. The different structures containing tight junction proteins in epidermal and other stratified epithelial cells, including squamous cell metaplasia. Eur. J. Cell Biol. 2007; 86; 645-655.
54. Ogasawara N, Kojima T, Go M et al. Induction of JAM-A during differentiation of human THP-1 dendritic cells. Biochem. Biophys. Res. Commun. 2009; 389; 543-549.
55. Kubo A, Nagao K, Yokouchi M et al. External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J. Exp. Med. 2009; 206; 2937-2946.
56. Ohkuni T, Kojima T, Ogasawara N et al. Expression and localization of tricellulin in human nasal epithelial cells in vivo and in vitro. Med. Mol. Morphol. 2009; 42; 204-211.
57. Kondoh A, Takano K, Kojima T et al. Altered expression of claudin-1, claudin-7, and tricellulin regardless of human papilloma virus infection in human tonsillar squamous cell carcinoma. Acta Otolaryngol. 2011; 131; 861-868.